Login / Signup

Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population-based, propensity-score-matched cohort study.

Shihchen KuoChun-Ting YangJin-Shang WuHuang-Tz Ou
Published in: Diabetes, obesity & metabolism (2018)
Initiation of fourth-line insulin therapy can be considered for patients with T2DM with triple OAD therapy failure, and the importance of awareness and prevention of hypoglycaemia among insulin-treated patients with T2DM cannot be overstated.
Keyphrases
  • type diabetes
  • glycemic control
  • stem cells
  • cross sectional
  • cell therapy
  • skeletal muscle
  • newly diagnosed